APA

Yilmaz M. I., Siriopol D., Saglam M., Kurt Y. G., Unal H. U., Eyileten T., Gok M., Cetinkaya H., Oguz Y., Sari S., Vural A., Mititiuc I., Covic A. & Kanbay M. (20151214). Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. : Kidney international.

Chicago

Yilmaz Mahmut I, Siriopol Dimitrie, Saglam Mutlu, Kurt Yasemin G, Unal Hilmi U, Eyileten Tayfun, Gok Mahmut, Cetinkaya Hakki, Oguz Yusuf, Sari Sebahattin, Vural Abdulgaffar, Mititiuc Irina, Covic Adrian and Kanbay Mehmet. 20151214. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. : Kidney international.

Harvard

Yilmaz M. I., Siriopol D., Saglam M., Kurt Y. G., Unal H. U., Eyileten T., Gok M., Cetinkaya H., Oguz Y., Sari S., Vural A., Mititiuc I., Covic A. and Kanbay M. (20151214). Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. : Kidney international.

MLA

Yilmaz Mahmut I, Siriopol Dimitrie, Saglam Mutlu, Kurt Yasemin G, Unal Hilmi U, Eyileten Tayfun, Gok Mahmut, Cetinkaya Hakki, Oguz Yusuf, Sari Sebahattin, Vural Abdulgaffar, Mititiuc Irina, Covic Adrian and Kanbay Mehmet. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. : Kidney international. 20151214.